ArticleCritical care science2023
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.
Caio de Assis Moura Tavares et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papertrialcites it